Literature DB >> 24577505

Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies.

Emanuele Amodio1, Claudio Costantino1, Sara Boccalini2, Fabio Tramuto1, Carmelo M Maida1, Francesco Vitale1.   

Abstract

Streptococcus pneumoniae is a major cause of human infectious diseases worldwide. Despite this documented evidence, data on pneumococcal disease rates among general populations are scant because of the frequent lack of cultural identification. In this study we propose a model for estimating the burden of pneumococcal pneumonia on hospitalizations. The study was performed by analyzing administrative and clinical data of patients aged 50 years or older, resident in Sicily, and hospitalized, from 2005 to 2012. Demographic information, admission/discharge dates, discharge status, and up to 6 discharge diagnoses coded according to ICD-9 CM were collected for each hospitalized patient. During the 8-year study period, a total of 72,372 hospitalizations with at least one ICD-9 CM diagnosis code suggestive of all-cause pneumonia were recorded. Of these, 1943 (2.7%) hospitalizations had specific ICD-9 CM diagnosis codes for pneumococcal pneumonia. According to the proposed model, 16,541 (22.9%) pneumonia out of all-cause pneumonia was estimated to be attributable to S. pneumoniae. Pneumococcal pneumonia and model-estimated pneumococcal pneumonia had mean hospitalization rates of 13.4 and 113.3/100,000, respectively, with a decreasing temporal trend. The risk of hospitalization for pneumococcal pneumonia was strongly correlated with age (P<0.001). Our model provides data usable to construct suitable decisional models for the decision-makers and could allow to the responsibles of healthcare facilities to assess the budget impact if they hypothesize to offer vaccination for pneumococcal disease to certain cohorts of subjects aged 50 years or older. In our area, the high estimated hospitalization rates among adults aged ≥65 years suggest the need to implement effective preventive strategies (e.g., vaccination) tailored for these groups.

Entities:  

Keywords:  Sicily; Streptococcus pneumoniae; hospitalizations; model estimating; pneumococcal pneumonia

Mesh:

Substances:

Year:  2014        PMID: 24577505      PMCID: PMC4896611          DOI: 10.4161/hv.27947

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  18 in total

1.  Use of 7-valent pneumococcal conjugate vaccine in EU.

Authors:  P L Lopalco
Journal:  Euro Surveill       Date:  2006-12-07

2.  Cost-effectiveness of vaccinating for invasive pneumococcal disease in the elderly in the Lazio region of Italy.

Authors:  Monica Merito; Paolo Giorgi Rossi; Jessica Mantovani; Filippo Curtale; Piero Borgia; Gabriella Guasticchi
Journal:  Vaccine       Date:  2006-08-18       Impact factor: 3.641

3.  Pneumococcal conjugate vaccine for childhood immunization--WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-03-23

4.  Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy.

Authors:  Sara Boccalini; Angela Bechini; Miriam Levi; Emila Tiscione; Roberto Gasparini; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

Review 5.  Burden of community-acquired pneumonia in North American adults.

Authors:  Thomas M File; Thomas J Marrie
Journal:  Postgrad Med       Date:  2010-03       Impact factor: 3.840

6.  [Active surveillance of invasive pneumococcal diseases in Sicilian children (2009-2011)].

Authors:  Emanuele Amodio; Antonino Bella; Giuseppe Nicoletti; Stefania Stefani; Francesco Vitale
Journal:  Ig Sanita Pubbl       Date:  2013 Jan-Feb

7.  The burden of hospitalised pneumonia in Lazio, Italy, 1997-1999.

Authors:  P Giorgi Rossi; N Agabiti; A Faustini; C Ancona; V Tancioni; F Forastiere; C A Perucci
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

8.  Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy.

Authors:  Paolo Giorgi-Rossi; Monica Merito; Piero Borgia
Journal:  Health Policy       Date:  2008-07-18       Impact factor: 2.980

9.  Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies.

Authors:  R E Guevara; J C Butler; B J Marston; J F Plouffe; T M File; R F Breiman
Journal:  Am J Epidemiol       Date:  1999-02-01       Impact factor: 4.897

10.  International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia.

Authors:  Ewoudt M W van de Garde; Jan Jelrik Oosterheert; Marc Bonten; Robert C Kaplan; Hubert G M Leufkens
Journal:  J Clin Epidemiol       Date:  2007-02-23       Impact factor: 6.437

View more
  8 in total

1.  A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012.

Authors:  Angela Bechini; Cristina Taddei; Alessandro Barchielli; Miriam Levi; Emilia Tiscione; Maria Grazia Santini; Fabrizio Niccolini; Maria Teresa Mechi; Donatella Panatto; Daniela Amicizia; Chiara Azzari; Paolo Bonanni; Sara Boccalini
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

2.  Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Authors:  Adoración Navarro-Torné; Eva Agostina Montuori; Vasiliki Kossyvaki; Cristina Méndez
Journal:  Hum Vaccin Immunother       Date:  2021-06-09       Impact factor: 4.526

3.  An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign.

Authors:  Donatella Panatto; Alexander Domnich; Roberto Gasparini; Paolo Bonanni; Giancarlo Icardi; Daniela Amicizia; Lucia Arata; Stefano Carozzo; Alessio Signori; Angela Bechini; Sara Boccalini
Journal:  J Med Internet Res       Date:  2016-12-02       Impact factor: 5.428

4.  Evaluation of chest radiography, lytA real-time PCR, and other routine tests for diagnosis of community-acquired pneumonia and estimation of possible attributable fraction of pneumococcus in northern Togo.

Authors:  A Blake; B M Njanpop-Lafourcade; J N Telles; A Rajoharison; M S Makawa; K Agbenoko; S Tamekloe; J E Mueller; H Tall; B D Gessner; G Paranhos-Baccalà; J C Moïsi
Journal:  Epidemiol Infect       Date:  2016-11-17       Impact factor: 2.451

5.  Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: Which was the impact of universal pneumococcal pediatric vaccination?

Authors:  Sara Boccalini; Ornella Varone; Martina Chellini; Luca Pieri; Antonino Sala; Cesare Berardi; Paolo Bonanni; Angela Bechini
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

6.  Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey.

Authors:  J P Sevilla; Andrew Stawasz; Daria Burnes; Anubhav Agarwal; Basak Hacibedel; Kerem Helvacioglu; Reiko Sato; David E Bloom
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

7.  Estimation of the incidence of hospitalization for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older.

Authors:  Trude Marie Lyngstad; Anja Bråthen Kristoffersen; Brita Askeland Winje; Anneke Steens
Journal:  Epidemiol Infect       Date:  2022-04-04       Impact factor: 4.434

Review 8.  Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination.

Authors:  Andrea Orsi; Filippo Ansaldi; Cecilia Trucchi; Roberto Rosselli; Giancarlo Icardi
Journal:  Int J Mol Sci       Date:  2016-07-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.